2QD1 image
Entry Detail
PDB ID:
2QD1
Keywords:
Title:
2.2 Angstrom Structure of the human ferrochelatase variant E343K with substrate bound
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2007-06-20
Release Date:
2007-10-30
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.26
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Ferrochelatase
Mutations:E343K
Chain IDs:A, B, C, D
Chain Length:359
Number of Molecules:4
Biological Source:Homo sapiens
Primary Citation
A pi-Helix Switch Selective for Porphyrin Deprotonation and Product Release in Human Ferrochelatase.
J.Mol.Biol. 373 1006 1016 (2007)
PMID: 17884090 DOI: 10.1016/j.jmb.2007.08.040

Abstact

Ferrochelatase (protoheme ferrolyase, EC 4.99.1.1) is the terminal enzyme in heme biosynthesis and catalyzes the insertion of ferrous iron into protoporphyrin IX to form protoheme IX (heme). Due to the many critical roles of heme, synthesis of heme is required by the vast majority of organisms. Despite significant investigation of both the microbial and eukaryotic enzyme, details of metal chelation remain unidentified. Here we present the first structure of the wild-type human enzyme, a lead-inhibited intermediate of the wild-type enzyme with bound metallated porphyrin macrocycle, the product bound form of the enzyme, and a higher resolution model for the substrate-bound form of the E343K variant. These data paint a picture of an enzyme that undergoes significant changes in secondary structure during the catalytic cycle. The role that these structural alterations play in overall catalysis and potential protein-protein interactions with other proteins, as well as the possible molecular basis for these changes, is discussed. The atomic details and structural rearrangements presented herein significantly advance our understanding of the substrate binding mode of ferrochelatase and reveal new conformational changes in a structurally conserved pi-helix that is predicted to have a central role in product release.

Legend

Protein

Chemical

Disease

Primary Citation of related structures